# Safety and Effectiveness Study of Chemotherapy and Ziv-aflibercept to Treat Metastatic Colorectal Cancer

> **NCT01889680** · PHASE2 · WITHDRAWN · sponsor: **NSABP Foundation Inc**

## Conditions studied

- Colorectal Cancer
- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** 5-FU
- **DRUG:** LV
- **DRUG:** ziv-aflibercept
- **DRUG:** mFOLFOX6

## Key facts

- **NCT ID:** NCT01889680
- **Lead sponsor:** NSABP Foundation Inc
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-11
- **Primary completion:** 2016-05
- **Final completion:** 2018-05
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2014-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01889680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01889680, "Safety and Effectiveness Study of Chemotherapy and Ziv-aflibercept to Treat Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01889680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*